Medical Marijuana (MMJ)

A long history of cannabis discoveries and research has put Israel at the forefront of medical cannabis developments, worldwide collaborations, and investor activity.

A review of the literature to examine the analgesic properties of cannabis.

What changes need to be adopted in our industry to make the transition to the pharmaceutical industry testing paradigm?

Top researchers discuss what they are working on, and how big data is helping collect information for better science about a complicated plant.

David L. Nathan, MD, DFAPA, President, Board of Directors, Doctors for Cannabis Regulations (DFCR), discusses how the DFCR was formed, the efforts they have been making in the cannabis field, and plans for the future of the organization.

In honor of National Women’s Month, Josh Crossney highlights some of the amazing women that will be speaking at the first Cannabis Science Conference East show.

Ricki Lake discusses returning to Baltimore to speak at CSC East and her award-winning documentary, Weed the People.

Here we take a closer look at Australia’s medical cannabis program, the laws surrounding it, and speak to Australian pharmacist Paul Mavor.

Dr. Ethan Russo, Director of Research and Development for the International Cannabis and Cannabinoids Institute (ICCI), recently spoke with us about some of his recent research efforts, cannabis dosing, and his continued push to change the stigma against cannabis as a medicine.

Paul Mavor, an Australian and UK licensed pharmacist and the CEO and Founder of Health House International, recently spoke to us about Australia’s medical cannabis program, the testing and regulations in place, and the future outlook for cannabis in his country.

The New Zealand government passed a law on December 11, 2018, that will establish a regulated medical cannabis scheme within one year.